185 related articles for article (PubMed ID: 10225856)
41. The limited role of pneumolysin in the pathogenesis of pneumococcal meningitis.
Friedland IR; Paris MM; Hickey S; Shelton S; Olsen K; Paton JC; McCracken GH
J Infect Dis; 1995 Sep; 172(3):805-9. PubMed ID: 7658074
[TBL] [Abstract][Full Text] [Related]
42. Adjuvant TACE inhibitor treatment improves the outcome of TLR2-/- mice with experimental pneumococcal meningitis.
Echchannaoui H; Leib SL; Neumann U; Landmann RM
BMC Infect Dis; 2007 Apr; 7():25. PubMed ID: 17428319
[TBL] [Abstract][Full Text] [Related]
43. Experimental pneumococcal meningitis: role of leukocytes in pathogenesis.
Ernst JD; Decazes JM; Sande MA
Infect Immun; 1983 Jul; 41(1):275-9. PubMed ID: 6862627
[TBL] [Abstract][Full Text] [Related]
44. Multiple therapeutic effects of adjunctive baicalin therapy in experimental bacterial meningitis.
Tang YJ; Zhou FW; Luo ZQ; Li XZ; Yan HM; Wang MJ; Huang FR; Yue SJ
Inflammation; 2010 Jun; 33(3):180-8. PubMed ID: 20033479
[TBL] [Abstract][Full Text] [Related]
45. Elimination of blood-derived macrophages inhibits the release of interleukin-1 and the entry of leukocytes into the cerebrospinal fluid in experimental pneumococcal meningitis.
Zysk G; Brück W; Huitinga I; Fischer FR; Flachsbarth F; van Rooijen N; Nau R
J Neuroimmunol; 1997 Mar; 73(1-2):77-80. PubMed ID: 9058762
[TBL] [Abstract][Full Text] [Related]
46. Effects of Toll-like receptor 2 agonist Pam(3)CysSK(4) on inflammation and brain damage in experimental pneumococcal meningitis.
Sellner J; Grandgirard D; Gianinazzi C; Landmann RM; Leib SL
J Neuroimmunol; 2009 Jan; 206(1-2):28-31. PubMed ID: 19012971
[TBL] [Abstract][Full Text] [Related]
47. A kinetic study of the cytokine/chemokines levels and disruption of blood-brain barrier in infant rats after pneumococcal meningitis.
Barichello T; Pereira JS; Savi GD; Generoso JS; Cipriano AL; Silvestre C; Petronilho F; Dal-Pizzol F; Vilela MC; Teixeira AL
J Neuroimmunol; 2011 Apr; 233(1-2):12-7. PubMed ID: 21109308
[TBL] [Abstract][Full Text] [Related]
48. Dexamethasone treatment of lipopolysaccharide-induced meningitis in rabbits that mimics magnification of inflammation following antibiotic therapy.
Rooney P; Bilbe G; Zak O; O'Reilly T
J Med Microbiol; 1995 Jul; 43(1):37-44. PubMed ID: 7608953
[TBL] [Abstract][Full Text] [Related]
49. Tumor necrosis factor-alpha and interleukin-1 beta in cerebrospinal fluid of patients with coccidioidal meningitis during therapy with fluconazole. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Ampel NM; Ahmann DR; Delgado KL; Galgiani JN; Cloud GA
J Infect Dis; 1995 Jun; 171(6):1675-8. PubMed ID: 7769317
[TBL] [Abstract][Full Text] [Related]
50. Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients.
Mustafa MM; Ramilo O; Sáez-Llorens X; Olsen KD; Magness RR; McCracken GH
Am J Dis Child; 1990 Aug; 144(8):883-7. PubMed ID: 2116086
[TBL] [Abstract][Full Text] [Related]
51. Interleukin-1beta and tumor necrosis factor-alpha in cerebrospinal fluid of children with bacterial meningitis.
Tang RB; Lee BH; Chung RL; Chen SJ; Wong TT
Childs Nerv Syst; 2001 Aug; 17(8):453-6. PubMed ID: 11508533
[TBL] [Abstract][Full Text] [Related]
52. Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally.
Ostergaard C; Yieng-Kow RV; Larsen CG; Mukaida N; Matsushima K; Benfield T; Frimodt-Møller N; Espersen F; Kharazmi A; Lundgren JD
Clin Exp Immunol; 2000 Nov; 122(2):207-11. PubMed ID: 11091276
[TBL] [Abstract][Full Text] [Related]
53. Increased levels of cytokines in cerebrospinal fluid of children with aseptic meningitis caused by mumps virus and echovirus 30.
Sulik A; Kroten A; Wojtkowska M; Oldak E
Scand J Immunol; 2014 Jan; 79(1):68-72. PubMed ID: 24313836
[TBL] [Abstract][Full Text] [Related]
54. Cerebrospinal fluid interleukin-1 beta/interleukin-1 receptor antagonist balance and tumor necrosis factor-alpha concentrations in tuberculous, viral and acute bacterial meningitis.
Akalin H; Akdiş AC; Mistik R; Helvaci S; Kiliçturgay K
Scand J Infect Dis; 1994; 26(6):667-74. PubMed ID: 7747089
[TBL] [Abstract][Full Text] [Related]
55. Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis.
Tuomanen E; Hengstler B; Rich R; Bray MA; Zak O; Tomasz A
J Infect Dis; 1987 May; 155(5):985-90. PubMed ID: 3470394
[TBL] [Abstract][Full Text] [Related]
56. S100B in the cerebrospinal fluid--a marker for glial damage in the rabbit model of pneumococcal meningitis.
Schmidt H; Gerber J; Stuertz K; Djukic M; Bunkowski S; Fischer FR; Otto M; Nau R
Neurosci Lett; 2010 May; 475(2):104-7. PubMed ID: 20347934
[TBL] [Abstract][Full Text] [Related]
57. Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis.
Kornelisse RF; Hack CE; Savelkoul HF; van der Pouw Kraan TC; Hop WC; van Mierlo G; Suur MH; Neijens HJ; de Groot R
Infect Immun; 1997 Mar; 65(3):877-81. PubMed ID: 9038291
[TBL] [Abstract][Full Text] [Related]
58. Induced hypothermia in experimental pneumococcal meningitis.
Angstwurm K; Reuss S; Freyer D; Arnold G; Dirnagl U; Schumann RR; Weber JR
J Cereb Blood Flow Metab; 2000 May; 20(5):834-8. PubMed ID: 10826534
[TBL] [Abstract][Full Text] [Related]
59. New antibodies as adjunctive therapies for Gram-positive bacterial meningitis.
Tuomanen E; Baruch A
Pediatr Infect Dis J; 1989 Dec; 8(12):923-8. PubMed ID: 2696931
[No Abstract] [Full Text] [Related]
60. Inhibition of indoleamine 2,3-dioxygenase prevented cognitive impairment in adult Wistar rats subjected to pneumococcal meningitis.
Barichello T; Generoso JS; Simões LR; Elias SG; Tashiro MH; Dominguini D; Comim CM; Vilela MC; Teixeira AL; Quevedo J
Transl Res; 2013 Dec; 162(6):390-7. PubMed ID: 23994082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
